Onaiza Cadoret-Manier
Director/Board Member en ARDELYX, INC. .
Fortuna: 2 M $ al 31/03/2024
Perfil
Onaiza Cadoret-Manier is an Independent Director at Ardelyx, Inc. since 2020 and at Ventyx Biosciences, Inc. since 2023.
Previously, she held the position of Vice President-Respiratory Franchise at Genentech, Inc. from 2011 to 2018.
She also served as the Chief Commercial Officer at GRAIL LLC and Grail Biosciences from 2018 to 2019.
In addition, she was the EVP, Chief Product Strategy & Operations Officer at Ionis Pharmaceuticals, Inc. from 2020 to 2024.
Ms. Cadoret-Manier completed her undergraduate degree at Queens College in 1985 and obtained an MBA from The University of Chicago in 1989.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 02/02/2024 | 35 825 ( 0.02% ) | 2 M $ | 31/03/2024 | |
ARDELYX, INC.
0.05% | 15/06/2023 | 110 150 ( 0.05% ) | 804 095 $ | 31/03/2024 |
VENTYX BIOSCIENCES, INC.
-.--% | 21/01/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Cargos activos de Onaiza Cadoret-Manier
| Empresas | Cargo | Inicio |
|---|---|---|
| ARDELYX, INC. | Director/Board Member | 12/03/2020 |
| VENTYX BIOSCIENCES, INC. | Director/Board Member | 11/01/2023 |
Antiguos cargos conocidos de Onaiza Cadoret-Manier.
| Empresas | Cargo | Fin |
|---|---|---|
| IONIS PHARMACEUTICALS, INC. | Chief Operating Officer | 15/03/2024 |
GRAIL LLC
 GRAIL LLC Electronic Equipment/InstrumentsElectronic Technology GRAIL LLC is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA. | Corporate Officer/Principal | 01/05/2019 |
| Grail Biosciences | Corporate Officer/Principal | 01/01/2019 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/05/2018 |
Formación de Onaiza Cadoret-Manier.
| Queens College | Undergraduate Degree |
| The University of Chicago | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| IONIS PHARMACEUTICALS, INC. | Health Technology |
| ARDELYX, INC. | Health Technology |
| VENTYX BIOSCIENCES, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
GRAIL LLC
GRAIL LLC Electronic Equipment/InstrumentsElectronic Technology GRAIL LLC is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA. | Electronic Technology |
| Grail Biosciences |
- Bolsa de valores
- Insiders
- Onaiza Cadoret-Manier
